Coronavirus Update: Clover Begins Twin Track Trials With GSK And Dynavax
Plus: Are UK's New Takeover Laws Prompted By AstraZeneca Fears?
Executive Summary
Clover enters the clinical trial stage in race to develop a vaccine, while the UK moves to protect a range of key industries from foreign takeover, including vaccines manufacturers. Meanwhile, confirmed cases in Beijing continue to rise.
You may also be interested in...
Coronavirus Update: Another Vaccine Disappointment For GSK
After suffering a setback in its joint venture with Sanofi, GlaxoSmithKline has been dropped by another vaccine partner, Clover, as it looks for the best adjuvant for its COVID-19 candidate.
Coronavirus Update: Moderna Set For Bigger Test As Vaccine Trials Begin In Older People
Moderna's vaccine has shown encouraging early results in younger adults, but over-55s and over-70s cohorts represent a bigger safety and efficacy hurdle.
Coronavirus Update: New Clinical Trials Network Could Help Pick Vaccine, Antibody Winners Faster
Plus: the World Health Organization has commissioned an independent panel to look at pandemic responses, while the emergence of an unknown pneumonia in Kazakstan is causing concern.